Braidwell LP Xenon Pharmaceuticals Inc. Transaction History
Braidwell LP
- $3.19 Trillion
- Q2 2024
A detailed history of Braidwell LP transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Braidwell LP holds 2,560,573 shares of XENE stock, worth $115 Million. This represents 3.13% of its overall portfolio holdings.
Number of Shares
2,560,573
Previous 1,308,011
95.76%
Holding current value
$115 Million
Previous $56.3 Billion
77.3%
% of portfolio
3.13%
Previous 1.81%
Shares
7 transactions
Others Institutions Holding XENE
# of Institutions
221Shares Held
69.8MCall Options Held
59.7KPut Options Held
60.7K-
Avoro Capital Advisors LLC New York, NY5.67MShares$255 Million3.02% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.42MShares$199 Million1.86% of portfolio
-
Wellington Management Group LLP Boston, MA3.83MShares$172 Million0.03% of portfolio
-
Commodore Capital LP New York, NY2.75MShares$124 Million9.63% of portfolio
-
Capital World Investors Los Angeles, CA2.68MShares$121 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.8B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...